Pathway to multi-modal manufacturing

Today’s product pipelines span an extraordinary range, from mature modalities to emerging platforms such as cell and gene therapies. For manufacturers whose R&D and production capabilities must accommodate this range, the challenge of bringing therapies to patients is now more complex than ever. Industry is therefore rethinking its fundamental approach to manufacturing because traditional purpose-built facilities, ideal for single-product manufacturing, can quickly become stranded assets for companies with evolving pipelines. What manufacturers need instead is a more adaptive model — one that can pivot quickly, enabling faster capacity increases without elevated capital costs, regenerated design processes or lengthy construction timelines. Multi-modal manufacturing can be a catalyst for this transformation. Yet, it is not the right approach for everyone, so determining whether this model is the right fit — and if so, how to integrate it — requires careful evaluation. This paper will help you assess the multi-modal paradigm. It is designed to support manufacturers considering a shift to multi-modal manufacturing and seeking a clear, balanced view of the opportunities and challenges involved. At its full potential, multi-modal manufacturing can cut capital delivery costs, improve utilization and allow you to consolidate key supply chain inputs within a single building. By leveraging shared infrastructure and utilities, this approach also cuts waste and conserves energy — a critical sustainability advantage. Using the insights and practical guidance in our paper will help you evaluate your business objectives, weigh trade-offs and decide whether multi-modal manufacturing is the right choice for your future.